Analysis of Allogeneic and Syngeneic Bone Marrow Stromal Cell Graft Survival in the Spinal Cord
Bone marrow stromal cells (MSC) are attractive candidates for developing cell therapies for central nervous system (CNS) disorders. They can be easily obtained, expanded in culture, and promote modest functional recovery following transplantation into animal models of injured or degenerative CNS. Wh...
Main Authors: | Sharon A. Swanger, Birgit Neuhuber, B. Timothy Himes, Ajay Bakshi, Itzhak Fischer Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2005-11-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000005783982594 |
Similar Items
-
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas
by: María Norte-Muñoz, et al.
Published: (2022-08-01) -
MSCs Become Collagen-Type I Producing Cells with Different Phenotype in Allogeneic and Syngeneic Bone Marrow Transplantation
by: Robert Maximilian Rusch, et al.
Published: (2021-05-01) -
The future of bone marrow stromal cell transplantation for the treatment of spinal cord injury
by: Mitsuhiro Enomoto
Published: (2015-01-01) -
Bone Marrow Stromal Cells for Repair of the Spinal Cord: Towards Clinical Application
by: Rishi D. S. Nandoe, et al.
Published: (2006-08-01) -
The Role of Brain-Derived Neurotrophic Factor in Bone Marrow Stromal Cell-Mediated Spinal Cord Repair
by: Gaby J. Ritfeld, et al.
Published: (2015-11-01)